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Abstract
Background: The expression and study of recombinant proteins in mammalian culture systems
can be complicated during the cell lysis procedure by contaminating proteins from cellular
compartments distinct from those within which the protein of interest resides and also by solubility
issues that may arise from the use of a single lysis buffer. Partial subcellular fractionation using
buffers of increasing stringency, rather than whole cell lysis is one way in which to avoid or reduce
this contamination and ensure complete recovery of the target protein. Currently published
protocols involve time consuming centrifugation steps which may require expensive equipment and
commercially available kits can be prohibitively expensive when handling large or multiple samples.
Findings:  We have established a protocol to sequentially extract proteins from cultured
mammalian cells in fractions enriched for cytosolic, membrane bound organellar, nuclear and
insoluble proteins. All of the buffers used can be made inexpensively and easily and the protocol
requires no costly equipment. While the method was optimized for a specific cell type, we
demonstrate that the protocol can be applied to a variety of commonly used cell lines and anticipate
that it can be applied to any cell line via simple optimization of the primary extraction step.
Conclusion:  We describe a protocol for the crude subcellular fractionation of cultured
mammalian cells that is both straightforward and cost effective and may facilitate the more accurate
study of recombinant proteins and the generation of purer preparations of said proteins from cell
extracts.
Findings
Background
The expression of recombinant proteins in cultured cell
lines has become an increasingly valuable tool for the
study of protein trafficking and function. In many or most
instances it is desirable to purify the recombinant protein
to allow accurate study of such functions. While this can
be complicated enough for a protein that is secreted into
the culture medium of the cell system, it becomes even
more daunting when the protein of interest resides within
the cell, perhaps in a single specific compartment. In this
case it is desirable to be able to isolate the target protein
with minimal contamination by other proteins, poten-
tially from compartments that the protein of interest may
never encounter. In most standard cell lysis procedures a
single lysis buffer, perhaps NP40 or RIPA is used to gener-
ate a total cell lysate essentially comprising a soup of pro-
teins and creating abundant opportunity for non specific
interactions.
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Another consideration that arises when one is studying a
mutant protein is the question of whether or not the pro-
tein is soluble in the extraction buffer used and thus
whether or not all of the protein has been harvested, ena-
bling an accurate assessment of the effect of the mutation
on the intracellular trafficking and function of the protein.
The use of more than one single lysis buffer can help to
address this issue, particularly if the stringency of the addi-
tional lysis buffer is higher, thus increasing the chances of
solubilizing any misfolded mutant proteins.
Additionally, many proteins do not reside permanently
within a given intracellular compartment but rather shut-
tle between compartments to carry out their functions e.g.
various transcription factors that shuttle between the
cytosol and the nucleus. A simple subcellular fractiona-
tion protocol that allows easy and reproducible genera-
tion of fractions representative of specific subcellular
organelles would facilitate the study of such dynamic
changes in intracellular protein localization.
Here we present a simple protocol for the isolation of
crude subcellular compartments from cultured mamma-
lian cells, sequentially generating fractions enriched for
cytosolic, membrane bound organellar, nuclear and insol-
uble proteins respectively.
Optimization of digitonin concentration for extraction of 
cytosolic proteins
The primary step of the protocol that we have developed
is the permeabilization of the plasma membrane using
digitonin to effectively release the contents of the cytosol.
Digitonin binds to and forms pores in membranes by
complexing with membrane cholesterol and other β-
hydroxysterols [1]. The extent of binding and permeabili-
zation thus depends upon the accessibility of the mem-
brane and its sterol composition [2]. At low
concentrations of digitonin the cholesterol rich plasma
membrane can be effectively solubilized with little to no
solubilization or permeabilization of intracellular mem-
branes that are lower in cholesterol such as the endoplas-
mic reticulum (ER) and mitochondrial membranes.
Similar concentration dependent effects on the degree of
cell lysis by digitonin have also been shown in studies on
parasites [3,4].
To optimize this primary step we tested a range of concen-
trations of digitonin from 0 to 200 μg/ml on Human
Embryonic Kidney (HEK293) cells, a cell line widely used
in the production of recombinant proteins [5]. Briefly,
cells were cultured in 12 well plates and were harvested by
trypsinisation followed by gentle lysis in buffer contain-
ing digitonin at a specified concentration. Following digi-
tonin extraction, the remaining cell pellets were then lysed
in NP40 lysis buffer to solubilize intracellular membrane
bound organelles such as the endoplasmic reticulum
(ER). Samples were then analyzed by 4-12% SDS-PAGE
followed by staining with Coomassie blue or by Western
blotting using antibodies to the cytosolic protein GAPDH
and the ER lumenal chaperone protein BiP/grp78 (Figure
1). Using this approach it was determined that at least 5
μg/ml digitonin was required to release the contents of the
cytosol from HEK293 cells, as judged by Coomassie blue
staining (Figure 1A) and colorimetric assay of protein
concentration in the extracts (Figure 1B). At this concen-
tration a significant amount of GAPDH was further
extracted by the NP40 buffer indicating incomplete
cytosolic extraction. Conversely at concentrations of 50
μg/ml digitonin or higher some BiP was also extracted
indicating partial lysis of the endoplasmic reticulum (Fig-
ure 1C). Thus it was decided that a concentration of 25 μg/
ml digitonin was optimal, giving near complete extraction
of the cytosol as indicated by GAPDH levels, with negligi-
ble permeabilization of the ER membrane, as indicated by
BiP levels. Following this starting concentration of digi-
tonin, the ER was then fully extractable using NP40 lysis
buffer. It is worth noting that regardless of the starting
concentration of digitonin in each case, the final total
amount of protein extracted remained the same indicating
that the initial digitonin extract did not have any refrac-
tory effects on the extractability of proteins in the subse-
quent step (Figure 1B).
Solubilization and extraction of nuclei and insoluble 
proteins
The remainder of the subcellular extraction protocol,
shown in its entirety in figure 2, was then applied. Briefly,
following the NP40 lysis step the nucleus was solubilized
and its contents released using RIPA buffer supplemented
with Benzonase (SIGMA) to digest DNA and RNA. As
shown in figure 3A the RIPA extraction successfully solu-
bilized the nuclear membrane as indicated by the pres-
ence of Lamin A, a nuclear membrane protein in the RIPA
extract that was not evident in any of the preceding
extracts. Also shown in this figure is the presence of the ER
membrane protein TRAM entirely in the NP40 extract. As
further demonstration of the distinction between frac-
tions we tested a panel of antibodies to various cytosolic,
ER, mitochondrial and nuclear proteins. As shown in fig-
ure 3B the cytosolic proteins AKT, GSK-3β, γ-Tubulin and
Caspase-3 are found almost exclusively in the digitonin
extract. Similarly the ER resident chaperones Calnexin and
Calreticulin are found predominantly in the NP40 extract,
as is the mitochondrial membrane protein VDAC/Porin.
We also transfected cells with a construct encoding V5/6×-
HIS epitope tagged ERGIC-53, a membrane component of
the ER-golgi intermediate compartment and this localized
almost exclusively to the NP40 fraction. Finding nuclear
proteins that localized predominantly to the RIPA fraction
was more challenging. The transcription factors p53 andBMC Research Notes 2009, 2:243 http://www.biomedcentral.com/1756-0500/2/243
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RAS were found in the NP40 and digitonin/NP40 extracts
respectively. It is to be expected that subcellular distribu-
tion of transcription factors would change depending
upon the cell cycle phase since all are initially synthesized
in the cytosol and traffic to the nucleus to function when
required. The fact that no p53 or RAS were evident in the
RIPA extract may be indicative of their absence for func-
tional reason or of permeabilization of the nuclear mem-
brane by NP40. Histone H3 however was found
exclusively in the RIPA extract. Taking these facts together
it is perhaps more appropriate to state that extraction with
NP40 solubilizes membrane organelles such as the ER,
Golgi and mitochondria and may also permeabilize the
nuclear membrane. Complete solubilization of the
Optimization of digitonin concentration for the extraction of cytosolic proteins Figure 1
Optimization of digitonin concentration for the extraction of cytosolic proteins. (A) HEK293 cells were plated at a 
density of 4 × 105 cells per well of a 12 well plate and were harvested 48 hours later. Cells were then lysed in 400 μl of buffer 
containing digitonin at the concentration indicated. Following centrifugation and collection of the supernatant the remaining 
cell pellet was further extracted in NP40 lysis buffer. An aliquot of each extract was then analysed by 4-12% SDS PAGE (Invit-
rogen #NP0322) followed by staining with Coomassie blue. (B) The concentration of protein in each extract was determined 
by colorimetric protein assay (Pierce #23232) and the results were plotted to demonstrate that total protein extracted was 
the same regardless of the starting concentration of digitonin. (C) Extracted proteins from each fraction were analyzed by 
Western blot using an anti GAPDH antibody (NOVUS Biologicals #300-221B) as a marker of the cytosol and an anti BiP anti-
body (SIGMA # G918) as a marker of the endoplasmic reticulum.
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Crude subcellular fractionation protocol Figure 2
Crude subcellular fractionation protocol. Recipes to prepare the required buffers are given at the top of the figure along 
with additional requirements for the protocol. The protocol is then listed step by step below.
BUFFER 1 BUFFER 2
Digitonin Buffer (Cytosol) NP40 Buffer (Membranous Organelles)
150 mM NaCl 150 mM NaCl
Buffer Preparation 
50 mM HEPES pH 7.4 50 mM HEPES pH 7.4
25 μg/ml digitonin (SIGMA #D141) 1 % NP40
BUFFER 3 BUFFER 4
RIPA Buffer (Nuclear Membrane) E-RIPA Extraction Buffer (Insoluble Proteins)
150 mM NaCl 150 mM NaCl
50 mM HEPES pH 7.4 50 mM HEPES pH 7.4
0 5 % Sodium Deoxycholate 0 5 % Sodium Deoxycholate 0.5 % Sodium Deoxycholate 0.5 % Sodium Deoxycholate
0.1 % Sodium Dodecyl Sulfate (SDS) 1 % Sodium Dodecyl Sulfate (SDS)
Benzonase (SIGMA# E1014) 100 mM Dithiothreitol (DTT)
(1 U/ml) add just before use
Additional Requirements:
Pre-warmed Trypsin solution, Ice cold PBS, Protease Inhibitors (Optional), Refrigerated centrifuge
Pt l
1. Remove the culture medium and add 500 Pl of trypsin solution per well and incubate at 37° C for 5
minutes. Dislodge the cells and aspirate the cell suspension pipetting it into 1 ml of cold culture
medium containing 10% Fetal Bovine Serum to quench the trypsin. Centrifuge at 100 RCF at 4° C
to pellet the cells.
2 Aspirate the supernatant and wash the cells by gentle pipetting into 1 ml of ice cold PBS
Protocol
2. Aspirate the supernatant and wash the cells by gentle pipetting into 1 ml of ice cold PBS.
Centrifuge the cell suspension again at 100 RCF at 4° C to pellet the cells. Aspirate the PBS and
resuspend the cell pellet by gentle pipetting in 400 Pl of ice cold buffer 1 containing protease
inhibitors if desired. Incubate the cell suspension end over end at 4°C for 10 minutes and then
centrifuge at 2,000 RCF to pellet the cells. Aspirate and keep the supernatant, this is the cytosol
enriched fraction. At this point if desired the cell pellet can be washed in ice cold PBS as earlier to
be sure of removal of any remaining digitonin extract.
3. Resuspend the cell pellet by vortexing in 400 Pl of ice cold buffer 2. Incubate on ice for 30 minutes
and then centrifuge at 7,000 RCF to pellet nuclei and cell debris. Aspirate and keep the
supernatant, this is the extract comprising membrane bound organelles such as the endoplasmic
reticulum (ER), golgi, mitochondria and some nuclear lumenal proteins. Once more, at this point
the cell pellet can be washed in ice cold PBS as earlier to be sure of removal of any remaining
NP40 extract.
4 Resuspend the nuclei and NP40 insoluble proteins by vortexing in 400 Pl of ice cold buffer 3 4. Resuspend the nuclei and NP40 insoluble proteins by vortexing in 400 Pl of ice cold buffer 3
containing Benzonase (1U/ml). Incubate the samples end over end at 4°C for 1 hour to allow
complete solubilization of nuclei and digestion of genomic DNA. (This step can be allowed to
proceed overnight with no adverse effects). Centrifuge the sample at 7,000 RCF for 10 minutes to
pellet insoluble proteins. Aspirate and keep the supernatant, this is the extract comprising nuclear
membranes and nuclear proteins. Once more, at this point the cell pellet can be washed in ice cold
PBS as earlier to be sure of removal of any remaining RIPA extract.
5. Extract remaining insoluble proteins in buffer 4 by vortexing and boiling. Centrifuge the extract at
maximum speed to pellet any remaining cell debris. At this point there will be no/little pellet at the
bottom of the tube. Keep the supernatant, this contains NP40/RIPA insoluble proteins. If desired
this extraction and the preceding RIPA extract can be combined into one concentrated extract. To
achieve this proceed with step 4 but using 320 Pl of ice cold buffer 3 containing Benzonase.
Following digestion of genomic DNA then add 40 Pl of 10 % SDS solution and 40 Pl of 1M DTT.BMC Research Notes 2009, 2:243 http://www.biomedcentral.com/1756-0500/2/243
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Solubilization and extraction of nuclei and insoluble proteins Figure 3
Solubilization and extraction of nuclei and insoluble proteins. (A) HEK293 cells were plated at a density of 4 × 105 
cells per well of a 12 well plate and processed according to the protocol in Figure 2. An aliquot of each extract was then ana-
lyzed by 4-12% SDS PAGE followed by staining with Coomassie blue or by Western blotting and probing with antibodies to the 
nuclear membrane protein Lamin A (SIGMA #L1293) or the ER membrane protein TRAM both highlighted by arrowheads. (B) 
Extracts generated in (A) were analyzed by 8 or 12% SDS PAGE followed by Western blotting and probing with antibodies to 
various cytosolic; Akt, Cell Signaling Technology (CST #9272), GSK-3β, (CST #9315), Caspase-3 (CST #9662) and γ-Tubulin 
(Santa Cruz Biotechnology, sc-7396), Organellar; Calnexin (SIGMA #C4731), Calreticulin (Stressgen #SPA-061), VDAC/Porin 
(SIGMA #V2139) and nuclear; p53 (CST #9282), RAS (Upstate Biotechnology #05-516) and Histone H3 (ABCAM #ab1791) 
proteins as indicated or with anti V5 antibody (Invitrogen #R96025) in the case of ERGIC-53. (C) Equal volumes of extracts 
were analyzed by 4-12% SDS-PAGE followed by staining with Coomassie blue and then silver staining. The bracket alongside 
the Coomassie stained gel shows the position of Histones in the RIPA nuclear extract and the asterisk next to the silver 
stained gel denotes a protein band unique to the E-RIPA extract. (D) The subcellular fractionation protocol was carried out in 
full and in duplicate. In one experiment the RIPA and E-RIPA extracts were prepared as a single extract as described in step 5 
of the protocol (Combined). In both cases following the E-RIPA extract any remaining pellet was extracted by boiling in LSB + 
DTT.
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿ A
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
￿
"
#
￿
￿
￿
￿
￿
￿
￿
￿
 
￿
￿
￿
￿
#
#
￿
!
B
$
%
&
’
(
’
)
*
+
,
-
.
,
(
’
,
/
+
0
.
)
)
.
*
+
,
-
.
,
(
0
1
$
)
.
+
,
*
+
,
-
.
,
(
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
2
￿
3
#
2
4
￿
ȕ
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
￿
5
 
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
6
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
ȕ
J
4
￿
"
7
"
￿
￿
￿
 
￿
#
￿
￿
#
!
4
￿
￿
￿
 
￿
￿
8
￿
￿
 
￿
￿
￿
￿
￿
￿
!
￿
3
￿
 
4
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
#
9
￿
#
￿
￿
￿
!
9
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
:
;
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
:
;
￿
￿
￿
￿
C
￿
￿
￿
￿
￿
￿
￿
<
￿
=
=
<
￿
=
=
￿
￿
￿
￿
9
￿
D
￿
!
3
"
￿
￿
￿
 
￿
￿
7
￿
￿
!
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
>
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
:
;
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
:
;
￿
￿
￿
?
@
A
?
@
A
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
￿
￿
￿
￿
#
#
￿
!
#
￿
￿
￿
￿
#
￿
￿
8
!
￿
#
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿BMC Research Notes 2009, 2:243 http://www.biomedcentral.com/1756-0500/2/243
Page 6 of 10
(page number not for citation purposes)
nuclear membrane and some nuclear resident proteins
however requires RIPA buffer as evidenced by the pres-
ence of Lamin A and Histone H3 in this extract.
Following extraction in RIPA buffer the final extraction in
enhanced RIPA buffer (E-RIPA) solubilized any remaining
proteins as shown in figure 3C by Coomassie stain and
subsequent silver stain. At least one distinct protein band
is present in the E-RIPA extract relative to the preceding
RIPA extract demonstrating extraction of previously insol-
uble protein. The Coomassie stain also shows the pres-
ence of Histones in the nuclear extract, as later confirmed
by Western blotting. While no pellet was visible following
the E-RIPA extraction, addition of 1× Laemmli sample
buffer to the tube followed by boiling and analysis by
SDS-PAGE and silver staining showed that no proteins
remained after the E-RIPA extraction (Figure 3D). Also
shown in this figure is the combinatorial approach from
step 5 in the protocol where the RIPA and E-RIPA extracts
are generated as one single concentrated extract, again
showing that no proteins remain after these steps.
Demonstration of the advantages of crude fractionation 
over whole cell lysis and scale up of the approach
To demonstrate the advantage of stepwise extraction of
proteins from cultured cells over whole cell lysis, we took
HEK293 cells in culture in a 12 well dish and lysed one
well directly in 400 μl of a typical NP40 lysis buffer, one
in 400 μl of a standard RIPA lysis buffer and another
according to our stepwise procedure. As shown in figure
4A by staining with Coomassie blue, direct lysis in either
NP40 or RIPA buffer generates a more complex sample
creating opportunities for potentially non specific protein
interactions, whereas a stepwise lysis approach generates
less heterogeneous samples enriched for particular
organelles. Western blot analysis shows that the recovery
of representative markers of each compartment appears to
be approximately equal indicating no loss of protein or
reduction in yield due to the stepwise approach. Interest-
ingly, NP40 does not appear to solubilize the nuclear
membrane of HEK293 cells since no Histones are evident
in the Coomassie stained gel and minimal Lamin A stain-
ing is observed by Western blot.
As proof of concept of the application of this method in
the generation of purer preparations of recombinantly
expressed proteins, we transiently transfected HEK293
cells with a construct encoding V5/6×-HIS tagged ERGIC-
53. Cells were then either lysed directly in NP40 or RIPA
buffer or were extracted sequentially according to our pro-
tocol. Subsequent analysis of extracts by SDS-PAGE fol-
lowed by staining with Coomassie blue or by Western
blotting and probing with an anti-V5 antibody demon-
strated the advantages of crude subcellular fractionation
over direct lysis. As can be seen in figure 4 purification of
ERGIC-53 from the NP40 extract obtained in the stepwise
procedure using Nickel Resin resulted in a purer prepara-
tion and higher yield of protein than from direct NP40 or
RIPA lysis due to less interference by proteins from the
cytosol becoming non-specifically bound to the resin/
ERGIC-53.
To illustrate our concept that not all proteins are recov-
ered in a single lysis step, particularly when overexpressed
in a recombinant system, we transfected cells with con-
structs encoding WT and mutant (MUT) cartilage oligo-
meric matrix protein (COMP) using lipofectamine 2000
(Invitrogen) as per manufacturer's instructions [6]. COMP
is a secreted glycoprotein of the extracellular matrices of
various skeletal tissues [7]. As shown in figure 4C the
majority of the protein resides in the NP40 extracted ER
fraction undergoing synthesis and trafficking. However a
significant amount of protein, particularly in the case of
MUT COMP, was recovered in the E-RIPA extract indica-
tive that it was misfolded and aggregated (Holden et al,
manuscript in preparation). Thus our approach allows for
the complete extraction of recombinantly expressed pro-
teins which may be critical in determining functional con-
sequences of mutations in any given protein.
We also considered that since some experimental
approaches require significant amounts of material, it
would be desirable to scale up this approach accordingly.
As such we calculated buffer volumes required based on
surface area of the culture vessel used as shown in Table 1,
assuming a proportional increase in cell number. Testing
of this scale up to the level of a 35 mm dish showed that
the fractionation efficiency was maintained (Figure 4D).
Application of the approach to other cell lines
To ensure that this approach was not only applicable to
HEK293 cells we repeated the procedure for two other
commonly used human cell lines, HT1080 [8] and HeLa
[9] cells beginning with the digitonin optimization step
for the extraction of cytosolic proteins. As shown in figure
5A the concentration of digitonin required for successful
extraction of cytosolic proteins with minimal perturbance
of the integrity of the ER was between 25 and 100 μg/ml
for each cell line. It is also worth noting that both HT1080
and HeLa cells displayed a greater sensitivity to lysis by
digitonin, some GAPDH being extractable even at 0.1 μg/
ml digitonin whereas HEK293 cells required at least 5 μg/
ml. This is not surprising given the mechanism of action
of digitonin on cell membranes and the natural variance
in membrane sterol composition of between 10 and 20%
that occurs between different cell types. In the application
of this technique to a given cell line, the decision regard-
ing the optimal concentration of digitonin to use for the
initial step will ultimately depend upon the desired out-
come i.e. whether one desires total extraction of cytosolicBMC Research Notes 2009, 2:243 http://www.biomedcentral.com/1756-0500/2/243
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Demonstration of the advantages of crude fractionation over whole cell lysis and scale up of the approach Figure 4
Demonstration of the advantages of crude fractionation over whole cell lysis and scale up of the approach. (A) 
HEK293 cells were plated at a density of 4 × 105 cells per well of a 12 well plate and subsequently lysed directly in NP40 or 
RIPA lysis buffer or processed according to the protocol in Figure 2 (Sequential). An aliquot of each extract was then analyzed 
by 4-12% SDS PAGE followed by staining with Coomassie blue or by Western blotting and probing with antibodies to various 
marker proteins of specific intracellular organelles as previously. (B) HEK293 cells were plated at a density of 4 × 105 cells per 
well of a 12 well dish and then transfected the next day in triplicate with 400 ng of a construct encoding V5/6×-HIS tagged 
ERGIC-53. Cells were extracted 48 hours later either directly in RIPA buffer, directly in NP40 buffer or according to our 
extraction protocol. Proteins were then partially purified from each extract using Nickel resin (SIGMA #P6611) and eluted 
proteins were analyzed by 10% SDS PAGE followed by staining with Coomassie blue or by Western blotting and probing with 
the anti V5 antibody. (C) HEK293 cells were plated at a density of 4 × 105 cells per well of a 12 well dish and then transfected 
the next day in with 1600 ng of pcDNA6/V5-His (Invitrogen) or constructs encoding WT or MUT COMP. Cells were har-
vested 48 hours later and extracted according to our protocol. (D) HEK293 cells were plated at a density of 4 × 105 cells per 
well of a 12 well dish or 8.4 × 105 cells per well of a 35 mm dish and processed according to the protocol in Figure 2. An aliq-
uot of each extract was then analyzed by 4-12% SDS PAGE followed by Western blotting and probing with antibodies to 
GAPDH, BiP and Lamin A.
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proteins and can tolerate some contamination from par-
tial lysis of other compartments, or whether one requires
a partial cytosolic extract essentially free from contamina-
tion. Additionally, the concentrations of digitonin can be
optimized within a narrower range following an initial
experiment such as this in order to maximize distinction
between fractions.
Continuation of the protocol using 100 μg/ml digitonin
for the cytosolic extraction in each case demonstrated
that, as was the case for HEK293 cells, distinct fractions
comprising membrane bound organellar proteins,
nuclear proteins and insoluble proteins could also be gen-
erated for HT1080 and HeLa cells (Figures 5B and 5C).
Due to the weakness of the signal from Lamin A we chose
to use an alternative marker of nuclear proteins, Histone
H3 (ABCAM) which clearly localized predominantly to
the nuclear extract. Once more, the silver stained gels in
figure 5C reveal the presence of unique proteins in the E-
RIPA extracts that are not present in the preceding RIPA
extract.
Discussion
We have developed a simple, inexpensive protocol for the
isolation of crude subcellular fractions of cultured cell
lines. The protocol uses simple buffers and equipment
and requires only approximately 2 hours from start to fin-
ish. While here we have presented data from three com-
monly used human cell lines, HEK293, HeLa and
HT1080, we anticipate that the technique can be applied
to any cell line in culture with some optimization of the
initial digitonin extraction step.
We envisage several useful applications of this technique;
the generation of purer preparations of recombinant pro-
teins from cultured cells, more thorough analysis of traf-
ficking and secretion of wild type and mutant proteins
and simplification of protein extracts for proteomic anal-
ysis.
The generation of purer preparations of recombinant pro-
teins from cultured cells is highly desirable. One such
advantage of having a purer preparation would poten-
tially be in the context of the study of protein-protein
interactions. Taking our expression and purification of
ERGIC-53 as a example, if one was to attempt to study the
interactions of this protein with other ER/Golgi proteins,
our stepwise fractionation approach of essentially remov-
ing the bulk of cytosolic proteins prior to lysis of the ER,
would potentially minimize non specific interactions
between ERGIC-53 and cytosolic proteins. While we do
not demonstrate this directly, figure 4B shows an approx-
imately 50 kDa protein (Protein-X) that appears to co-
purify with ERGIC-53 using our sequential lysis approach.
While this band is also apparent when direct NP40 and
RIPA lysis approaches are used, there are clearly other sim-
ilar sized proteins also present which may complicate the
identification of this band.
In the second case, studies of mutated recombinant pro-
teins via transfection of cultured cell lines can often be
misleading. In many cases, protein mutations lead to
aberrant folding which can in turn lead to intracellular
aggregation and insolubility in typical cell lysis buffers
such as NP40. Using the approach described here, essen-
tially all proteins from within a cell are effectively solubi-
lized by use of buffers of increasing stringency, thus
helping to ensure that every folded intermediate of a given
protein is extracted which may help to give a more accu-
rate picture of the effect of a mutation on the fate of a pro-
tein. We have ourselves, as shown briefly, recently used
this approach in the study of mutations in cartilage oligo-
meric matrix protein that cause the dwarfing condition
pseudoachondroplasia (Holden et al, manuscript in prep-
aration).
While we are aware that the use of digitonin and detergent
fractionation in the preparation of subcellular extracts is
not a novel concept, as far as we are aware our protocol as
presented here represents the first open access protocol
that encompasses simple stepwise subcellular fractiona-
tion of cultured mammalian cells in totality, giving a com-
plete extract of all cellular proteins. Given its simplicity,
reproducibility and cost effectiveness we feel that this pro-
tocol will be extremely useful to scientists across a broad
range of disciplines, particularly given its accessibility to
all in this format.
List of abbreviations
NP40: nonyl phenoxylpolyethoxylethanol; RIPA: Radio
immunoprecipitation assay; HEK293: Human embryonic
kidney 293; ER: Endoplasmic reticulum; DIGI: Digitonin;
VDAC: Voltage Dependent Anion Channel; ERGIC: ER to
golgi intermediate compartment; COMP: Cartilage oligo-
Table 1: Volumes of buffer required for protocol scale up 
according to culture vessel surface area.
Culture Vessel Surface Area (cm2)B u f f e r  V o l u m e  ( m l )
100 mm dish 55 5.8
60 mm dish 21 2.2
35 mm dish 8 0.84
6 well plate 9 0.95
12 well plate 3.8 0.4
24 well plate 2.0 0.2BMC Research Notes 2009, 2:243 http://www.biomedcentral.com/1756-0500/2/243
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Application of the approach to other cell lines Figure 5
Application of the approach to other cell lines. (A) HT1080 cells (2 × 105) and HeLa cells (1 × 105) were plated in the 
wells of a 12 well plate and the digitonin concentration required for optimal extraction of the cytosol was determined as in 
Figure1. (B) The remainder of the protocol from Figure 2 was then applied using 100 μg/ml digitonin as the optimal cytosolic 
extract in each case. An aliquot of each extract was then analyzed by 4-12% SDS PAGE followed by Western blotting and 
probing with antibodies to GAPDH, BiP and Histone H3 (Used as an alternative nuclear marker due to weakness of the Lamin 
A signal in HeLa cells). (C) Samples were analyzed by 4-12% SDS PAGE followed by staining with Coomassie blue and then sil-
ver staining showing the difference in protein composition of each sample. The bracket alongside the gels marks the position of 
Histones in the RIPA nuclear extract and the asterisk next to the silver stained gels denotes protein bands unique to the E-
RIPA extracts.
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meric matrix protein; LSB: Laemmli sample buffer; CNX:
Calnexin; CRT: Calreticulin.
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